Literature DB >> 3311348

Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors.

R S Greenberg1, D A Baumgarten, W S Clark, P Isacson, K McKeen.   

Abstract

Data collected by population-based cancer registries in Iowa and metropolitan Atlanta were evaluated to determine prognostic factors for gastrointestinal (n = 270) and bronchopulmonary (n = 151) carcinoids. The predictors considered in univariate and multivariate analyses were: age, sex, race, marital status, anatomic subsite, stage, occurrence of other malignancies, and surgery. For surgically treated gastrointestinal tumors, the cumulative percentages of survivors at five years were: appendix, 85.6%; small intestine, 66.0%; and large intestine, 37.7%. The likelihood of death from gastrointestinal carcinoids was found to be related independently to increasing age (P = 0.001), advanced stage (P less than 0.0001), location within the large intestine (P less than 0.0001), and occurrence of another malignancy (P = 0.02). The overall five-year survival rate for bronchopulmonary carcinoids was 87.6%, and lack of surgical treatment (P less than 0.0001) and advanced stage (P = 0.006) were associated independently with unfavorable prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3311348     DOI: 10.1002/1097-0142(19871115)60:10<2476::aid-cncr2820601022>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Gastrointestinal carcinoids: characterization by site of origin and hormone production.

Authors:  M W Onaitis; P M Kirshbom; T Z Hayward; F J Quayle; J M Feldman; H F Seigler; D S Tyler
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 2.  Sex differences in carcinoid syndrome: A gap to be closed.

Authors:  Rosaria M Ruggeri; Barbara Altieri; Erika Grossrubatcher; Roberto Minotta; Maria Grazia Tarsitano; Virginia Zamponi; Andrea MIsidori; Antongiulio Faggiano; Anna Maria Colao
Journal:  Rev Endocr Metab Disord       Date:  2022-03-16       Impact factor: 6.514

3.  Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.

Authors:  G B Turner; B T Johnston; D R McCance; A McGinty; R G P Watson; C C Patterson; J E S Ardill
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059

4.  Pulmonary carcinoid tumours: incidence, histology, and surgical outcome. A population-based study.

Authors:  Astridur Petursdottir; Johanna Sigurdardottir; Bjorn M Fridriksson; Arni Johnsen; Helgi J Isaksson; Hronn Hardardottir; Steinn Jonsson; Tomas Gudbjartsson
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-11-28

5.  Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

Authors:  E Mitry; E Baudin; M Ducreux; J C Sabourin; P Rufié; T Aparicio; T Aparicio; P Lasser; D Elias; P Duvillard; M Schlumberger; P Rougier
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

6.  Marital Status and Survival in Patients with Carcinoid Tumors.

Authors:  Erin K Greenleaf; Amanda B Cooper; Christopher S Hollenbeak
Journal:  Health Serv Insights       Date:  2016-04-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.